Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H13N3 |
InChIKeyVLMIUEHYKGMAHV-UHFFFAOYSA-N |
CAS Registry1446352-67-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NZ | 27 Apr 2013 |